Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > July 2005

« Previous month Next month »

MAP Pharma extends respiratory alliance with Elan

29-Jul-2005 - MAP Pharmaceuticals has broadened its agreement with Elan Corp to develop improved formulations of respiratory drugs to include combination asthma treatments and inhaled drugs for other lung diseases.

MIT engineers anti-cancer smart bomb

28-Jul-2005 - Scientists have developed a nanoparticle that can penetrate a tumour, cut off its blood supply and release a lethal dose of anti-cancer toxins, while leaving healthy cells unscathed.

IMA looks to China as Western markets fail to pick up

28-Jul-2005 - Italian processing machinery company IMA Group has decided to increase its investment in a Chinese joint venture to tap into a growth market at a time when its established territories...

Pilot-scale freeze drier launched by BPS

28-Jul-2005 - Biopharma Process Systems of the UK has extended the range of freeze driers it offers in the UK and Ireland with the launch of VirTual for pilot scale bulk freeze...

R&D spending per NME declines

28-Jul-2005 - According to a recent survey, the pharma industry spent an estimated $1.25 billion for each new molecular entity (NME) approved by the FDA in 2004. The figure represents the second...

Pharma managers sought as science journalists

28-Jul-2005 - Novis is currently seeking experts to develop as science journalists across several of its pharmaceutical and food industry news services.

DSM tops analyst forecasts in second quarter

27-Jul-2005 - Dutch chemicals group DSM reported better than expected second quarter results today, as higher selling prices in its industrial chemicals unit and lower fixed costs boosted margins, write Dominique Patton...

Evotec wins service contract from P&G Pharma

27-Jul-2005 - Germany's Evotec is to provide a broad range of pharmaceutical discovery and chemical development services to Procter & Gamble Pharmaceuticals in a lift for its outsourcing business.

Biopharma pulls Lonza back on track in first half

27-Jul-2005 - Swiss chemicals firm and contract manufacturer Lonza fulfilled its promise of stronger financial results in the first half of 2005, with profits coming in at the lower end of the...

Kirin buys transgenic cow firm Hematech

27-Jul-2005 - Japan's Kirin Brewery Co has bought Hematech of the US, acquiring the latter's core technology for the production of bovine-derived human polyclonal antibodies which could be useful in the development...

FlexPac to expand into pharma after Blackard acquisition

26-Jul-2005 - The acquisition of Flexible Packaging (FlexPac) of the US by the Blackard Group will spur the development of the company's technology into new industrial sectors, including pharmaceuticals.

Teva to regain generics lead with Ivax purchase

26-Jul-2005 - Teva Pharmaceutical Industries continued its bid for world domination in the generic pharmaceuticals sector yesterday with a $7.4 billion cash and stock bid for US company Ivax, reports Phil Taylor.

Price increases keep Akzo Nobel on track in 2Q

26-Jul-2005 - Dutch pharmaceuticals and chemicals giant Akzo Nobel reported second-quarter sales of €3.34 billion, up 6 per cent from the comparable period in 2004, thanks to price increases that overcame flat volumes.

Laboratory tool reveals linked loci

26-Jul-2005 - An improved new statistical method developed by genome researchers, is set to streamline the computation required to identify the potential locations in the genome, as well as linking more gene...

Acambis commences C. difficile vaccine trial

26-Jul-2005 - Acambis has commenced clinical trials of its investigational vaccine against Clostridium difficile (C. difficile) - a common hospital-acquired infection, in which a new virulent strain has emerged, causing sharp increases...

Alliance aims to improve actinomycete production

26-Jul-2005 - Microbia has entered into a research collaboration with A*STAR's Bioprocessing Technology Institute (BTI) in Singapore to improve the efficiency of pharmaceutical production from actinomycete bacteria.

Lab-scale blender boasts NIR analysis

25-Jul-2005 - Buck Systems, part of Niro Pharma Systems, has launched a laboratory-scale blender that allows users to analyse powders as they are being blended and monitor changing powder characteristics, achieving the...

Scientists discover molecule potential for Alzheimer's

25-Jul-2005 - Scientists from the University of California have discovered three molecules that show great potential in the development of new Alzheimer's drugs. The new therapy targets a protein that accumulates in...

Merck sees turnover rise across chemicals, pharma

25-Jul-2005 - Chemicals and pharmaceuticals firm Merck KGaA saw turnover rise but pretax earnings dip in the second quarter of 2005, although the results were skewed by the gain from its divestment...

Drug treatment mimics circadian rhythms

25-Jul-2005 - UK company Diurnal has received orphan product designation from the European Commission for a novel treatment that uses a drug delivery technology to match the body's circadian rhythms.

Maxim issued with novel cancer drug patent

25-Jul-2005 - Maxim Pharmaceuticals has been issued with a US patent that covers a novel class of potent apoptosis inducers with vascular targeting activity that inhibits microtubule formation - a prime drug...

Chiron vaccine facility will miss Begrivac production targets

25-Jul-2005 - Chiron says it will be unable to supply any Begrivac influenza vaccine to markets outside the US during the 2005/6 flu season, just days after admitting it has sterility problems...

Filters up, but bioreactors hold back Sartorius in 1H

25-Jul-2005 - Lab and process equipment company Sartorius closed the first half of 2005 with increases in sales revenue and earnings, with a good performance by its filter business driven by demand...

Q Chip extends MicroPlant collaboration

22-Jul-2005 - Cardiff-based drug delivery company Q Chip has extended its collaborative research deal with Biocompatibles International, a medical device company focused on the treatment of cardiovascular disease, cancer and benign tumours.

Provectus begins cancer treatment trials

22-Jul-2005 - Provectus Pharmaceuticals are to begin phase 1 clinical trials of new cancer treatment, PV-10, the company's new drug candidate for the treatment of metastatic melanoma (the most aggressive form of...

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...